0001104659-14-087784.txt : 20141219
0001104659-14-087784.hdr.sgml : 20141219
20141219102005
ACCESSION NUMBER: 0001104659-14-087784
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141217
FILED AS OF DATE: 20141219
DATE AS OF CHANGE: 20141219
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000890465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 870439579
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
BUSINESS PHONE: (908) 450-5300
MAIL ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rogus Joseph J
CENTRAL INDEX KEY: 0001299691
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23272
FILM NUMBER: 141297857
MAIL ADDRESS:
STREET 1: 550 HILLS DRIVE
STREET 2: 3RD FLOOR
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
4
1
a4.xml
4
X0306
4
2014-12-17
0
0000890465
NPS PHARMACEUTICALS INC
NPSP
0001299691
Rogus Joseph J
550 HILLS DRIVE
BEDMINSTER
NJ
07921
0
1
0
0
SVP Gbl Tech Oper Sup Chn Mgt
Common Stock
2014-12-17
4
M
0
5175
5.05
A
25326
D
Common Stock
2014-12-17
4
M
0
11292
3.34
A
36618
D
Common Stock
2014-12-17
4
S
0
16467
35.00
D
20151
D
Employee Stock Options (right to buy)
5.05
2014-12-17
4
M
0
5175
0
D
2018-07-15
Common Stock
5175
0
D
Employee Stock Options (right to buy)
3.34
2014-12-17
4
M
0
11292
0
D
2020-02-19
Common Stock
26782
74051
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
On July 15, 2008, the reporting person received a grant of 5,175 stock options under NPS Pharmaceuticals, Inc.'s (the "Issuer") 1998 Stock Option Plan. The options became exercisable based on the following vesting schedule: 28% on the first anniversary of the grant and 2% each month thereafter. As of the date of this filing, all 5,175 stock options have vested.
On February 19, 2010, the reporting person was granted options to purchase shares of common stock under the Issuer's 2005 Omnibus Incentive Plan, which are subject to both performance conditions and time-based vesting. As of the date of this filing, the performance criteria and the time-based criteria for 112,125 of these options has been satisfied. These options vested and became exercisable based on the following vesting schedule: 25% on each of the first four anniversaries of the date of grant.
/s/ Joseph J. Rogus, by Jill Thompson as attorney-in-fact
2014-12-18